MECHANISM OF ACTION
The Shredded Stack brings together three compounds that each approach fat metabolism from a different angle. AOD-9604 directly triggers fat cells to break down their stored fat, without raising growth-related hormones. MOTS-C switches on the body's exercise-response system (AMPK), raising the metabolic rate, improving how the body handles sugar, and pushing muscles to use more fat for fuel in research models. Tesamorelin stimulates growth hormone to specifically target visceral fat (the fat stored deep in the abdomen around the organs), the mechanism behind its FDA approval. Because they work through three different pathways at once, the theory is that the combined effect is greater than any single compound alone.
RESEARCH APPLICATIONS
- Multi-mechanism adipose tissue research protocol
- Visceral adiposity reduction (abdominal fat)
- Body recomposition research - lean mass preservation concurrent with adipose reduction
- Metabolic rate enhancement without stimulants
- Type 2 diabetes-adjacent metabolic research
RESEARCH HIGHLIGHTS
Complementary Fat Loss Mechanisms
AOD-9604 (lipolysis, no IGF-1 elevation), MOTS-C (AMPK/metabolic rate), Tesamorelin (visceral GH signal) provide three distinct, non-overlapping fat-reduction pathways.
Ref: See individual compound pages
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
2–8°C. Reconstituted blend follows most sensitive component (Tesamorelin: use within 3 hours if no preservative, or 21 days bacteriostatic).
Regulatory Status
Research compound blend. MOTS-C not WADA listed. Tesamorelin WADA S2 prohibited. AOD-9604 not explicitly listed on WADA prohibited list. SAHPRA: all components unscheduled.